Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ZymoGenetics claims court win versus King
Bizjournals.com
Friday, December 11, 2009 - 10:37am
tags:
King, ZymoGenetics, Recothrom
Sunesis Pharma's Impressive Gain: Hoping for a Dip
Seeking Alpha
Friday, December 11, 2009 - 10:36am
tags:
Sunesis, Voreloxin
AstraZeneca says high dose of Faslodex tops current dose at reducing breast cancer progression
Yahoo/AP
Friday, December 11, 2009 - 10:35am
tags:
breast cancer, Faslodex, AstraZeneca
FDA says cholesterol pill Crestor curbs heart problems in patients, but notes diabetes risk
Yahoo/AP
Friday, December 11, 2009 - 10:33am
tags:
Crestor, diabetes, AstraZeneca, FDA
Roche arthritis drug effective in late-stage study
Reuters
Friday, December 11, 2009 - 10:32am
tags:
Roche, arthritis, ocrelizumab
Genentech sheds pact as pipeline review claims another deal
Fierce Biotech
Friday, December 11, 2009 - 10:30am
tags:
pipelines, Genentech, Roche, Seattle Genetics, partnerships
Pharma Deal With White House Delays Health Reform
Pharmalot
Friday, December 11, 2009 - 10:29am
tags:
healthcare reform
Glaxo to Buy Stake in Intercell in Vaccines Alliance
Bloomberg
Friday, December 11, 2009 - 10:28am
tags:
Intercell, M&A, vaccines, GSK
Pfizer gets European authorization for Prevenar 13
Marketwatch
Friday, December 11, 2009 - 10:27am
tags:
Europe, Prevnar 13, vaccines, Pfizer
Showdown Over AIDS Drugs
Forbes
Friday, December 11, 2009 - 10:27am
tags:
AIDS, HIV, Merck, Gilead Sciences
Senators move to block drugmakers from mining Rx data
Yahoo/AP
Thursday, December 10, 2009 - 8:33pm
tags:
drug data, data mining, IMS, Merck, Pfizer
FDA panel: Gilead Sciences drug to treat deadly lung infection appears safe and effective
Yahoo/AP
Thursday, December 10, 2009 - 4:53pm
tags:
Gilead Sciences, FDA, Cayston
A Tale of Two Lillys
Motley Fool
Thursday, December 10, 2009 - 4:51pm
tags:
Eli Lilly
Bears Mauling This Drug Maker's Shares (Lilly)
CNBC
Thursday, December 10, 2009 - 4:49pm
tags:
Eli Lilly
Pfizer's R&D Productivity
In the Pipeline
Thursday, December 10, 2009 - 3:41pm
tags:
Pfizer, pipelines, R&D
Bone Drugs Appear to Cut Breast Cancer Risk
WSJ Online
Thursday, December 10, 2009 - 3:38pm
tags:
breast cancer, Merck, Fosamax, Roche, Boniva
Immunogen reports positive breast cancer drug data
Yahoo/AP
Thursday, December 10, 2009 - 11:09am
tags:
Immunogen, drug trials, breast cancer
Glaxo hands back another cancer drug to Cytokinetics
Fierce Biotech
Thursday, December 10, 2009 - 11:08am
tags:
Cytokinetics, GSK, cancer
Sanofi-Aventis Reaches Accord With Alopexx on Antibody
Bloomberg
Thursday, December 10, 2009 - 11:06am
tags:
Alopexx, Sanofi, antibodies, partnerships
Which Is the Better Opportunity: GlaxoSmithKline or Forest Labs?
Motley Fool
Thursday, December 10, 2009 - 11:05am
tags:
GSK, Forest Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.